Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

"We anticipate that three common acute clinical conditions—ischemic stroke, myocardial infarction, and pulmonary embolism—for which treatment with thrombolytics and anticoagulation are ...

Bayer is hoping that the antibody could provide an alternative to thrombolytics like t-PA, which are only moderately effective at dissolving blood clots in DVT. Thrombolytics frequently cause mild ...